WellDoc

18 articles about WellDoc

• Welldoc Receives 10th 510(k) Clearance from FDA for Award-Winning Diabetes Platform BlueStar®

  8/15/2023

  Welldoc Receives 10th 510(k) Clearance from FDA for Award-Winning Diabetes Platform BlueStar.

• CCS Announces Innovative Partnership with Welldoc and ZeOmega Aimed at Helping People with Chronic Conditions Lead Healthier Lives while Reducing Healthcare Costs

  10/13/2022

  CCS has announced a new technology partnership Welldoc and ZeOmega to expand its established LivingConnected® solution.

• Welldoc Granted 31st Patent for First-in-Class Chronic Care Platform

  6/16/2022

  Welldoc Granted 31st Patent for First-in-Class Chronic Care Platform.

• Welldoc and Dexcom Expand Strategic Partnership to Integrate Platforms and Offer Integrated Type 2 Diabetes Management Solution

  4/5/2021

  Welldoc, a trailblazer in digital health that is revolutionizing chronic condition management, and Dexcom, the leader in real-time continuous glucose monitoring (CGM), today announced the first customer for a new integrated offering to drive improved health for people with Type 2 diabetes. Welldoc will offer its BlueStar ® digital health

• 

  BioSpace Movers & Shakers, Sept. 11

  9/11/2020

  Biopharma and life sciences companies bolster their leadership teams and boards with these Movers & Shakers.

• Welldoc and Montana Diabetes Digital Health Learning Network Partner to Offer Digital Support to Those with Diabetes

  7/1/2020

  With 10.9% percent of adult Montanans diagnosed with diabetes, new remote patient monitoring solution will provide accessible care for those in rural settings   [01-July-2020]   COLUMBIA, Md. , July 1, 2020 /PRNewswire/ --  Welldoc , trailblazer in digital health with the first FDA-cleared Software as a Medical Device (SaMD) for diabetes, announced a collaboration with Th

• Welldoc's BlueStar® further expands use of digital tool for diabetes care within leading academic medical center

  6/11/2020

  Welldoc® , revolutionizing digital health with the first FDA-cleared Software as a Medical Device (SaMD) for diabetes, today announced the expansion of an agreement with Mass General Brigham (formerly Partners HealthCare). After conducting a 2-year program of Quality Improvement (QI) research with the Ambulatory Practice of the Future

• Welldoc Receives FDA Clearance for Long-Acting Insulin Support for Award-Winning Digital Health Solution BlueStar®

  6/3/2020

  Marks 8th FDA clearance for BlueStar, the only reimbursable software as a medical device for diabetes that integrates with all of a patient's existing devices

• Welldoc Announces Collaboration with Dexcom to Enhance the Value of BlueStar® with the Dexcom G6® CGM System

  3/11/2020

  Welldoc, announced today a collaboration with Dexcom, the global leader in continuous glucose monitoring (CGM) systems for people with diabetes.

• Welldoc and Redox Partner to Optimize Provider Interaction with Chronic Disease Management Platform

  2/25/2020

  Feb. 25, 2020 14:00 UTC Welldoc and Redox Partner to Optimize Provider Interaction with Chronic Disease Management Platform Partnership ensures bidirectional integration with EHRs and insights available at the point of care MADISON, Wis.--( BUSINESS WIRE )-- Welldoc , a leading digital health company revolutionizing chronic disease management, announced today its strategic partnership with Redox Inc. , the leading interoperability platform for healthcare data exchange.

• Welldoc Submits 510(k) for Long-Acting Insulin Support for Their Award-winning Digital Health Solution BlueStar®

  1/16/2020

  This is Welldoc's 8th 510(k) filing to the U.S. Food and Drug Administration

• Astellas and Welldoc Enter into Strategic Alliance for Digital Therapeutics

  11/21/2019

  Develop and commercialize digital health solutions globally for multiple therapeutic areas, including in Japan for diabetes patients

• Competitive Health Partners with Welldoc to Offer Digital Health Tool to Employers to Manage Their Type 2 Diabetes

  10/31/2019

  BlueStar® Will Now Be Available to 400,000+ Employees with Type 2 Diabetes through Competitive Health's SHOWBenefits Platform

• Validic and Welldoc Partner to Enhance Engagement for Individuals Living with Chronic Conditions

  4/30/2019

  Validic, and Welldoc announced their partnership to broaden the access and integration of personal health data within the Welldoc BlueStar® platform.

• LifeScan, Inc. Announces Strategic Collaboration With WellDoc To Advance Mobile Care Solutions For Type 2 Diabetes Patients

  3/1/2016

• WellDoc And American Diabetes Association's Maryland Chapter Announce A New Collaboration To Empower People With Type 2 Diabetes To Manage Their Condition

  9/16/2014

• Diabetes Care Goes Mobile as App Aims to Monitor Disease, WellDoc Study

  8/17/2012

• WellDoc and AstraZeneca PLC Collaborate to Develop Asthma Management Solution

  9/16/2008